SCHEMBL6289913

SCHEMBL6289913

CCc1cccc(F)c1Oc1ccccc1Oc1ccccc1Oc1cccc(Oc2ccccc2Oc2ccccc2Oc2c(F)cccc2CC)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 4/20 0.43
HTR2A P28223 2/20 0.43
AR P10275 1/20 0.40
CXCL8 P10145 2/20 0.40
SLC6A2 P23975 2/20 0.40
SLC6A3 Q01959 1/20 0.40
MTNR1B P49286 1/20 0.38
HRH1 P35367 1/20 0.37
ALDH1A1 P00352 3/20 0.37
HPGD P15428 2/20 0.37
HSD17B10 Q99714 2/20 0.37
KDM4E B2RXH2 2/20 0.37
GLA P06280 1/20 0.37
GAA P10253 1/20 0.37
CASP1 P29466 1/20 0.37
CASP7 P55210 1/20 0.37
CACNA1B Q00975 1/20 0.37
APBA1 Q02410 1/20 0.37
MAPK1 P28482 2/20 0.37
PKM P14618 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6293182 0.91 CXCL8 (0.46) SLC6A4CXCL8SLC6A2SLC6A3ALDH1A1
SCHEMBL6290180 0.82 GAA (0.49) SLC6A4HTR2AARSLC6A2SLC6A3
SCHEMBL1271069 0.81 GAA (0.50) SLC6A4HTR2AARSLC6A2SLC6A3
SCHEMBL29906998 0.81 GAA (0.50) SLC6A4HTR2AARSLC6A2SLC6A3
SCHEMBL6290359 0.75 AR (0.45) SLC6A4HTR2AARSLC6A2SLC6A3
SCHEMBL6290666 0.74 CXCL8 (0.46) SLC6A4HTR2AARCXCL8ALDH1A1
SCHEMBL6290619 0.73 PARP10 (0.50) SLC6A4CXCL8SLC6A2SLC6A3ALDH1A1
SCHEMBL21612712 0.73 HRH1 (0.46) SLC6A4SLC6A2HRH1ALDH1A1KDM4E
SCHEMBL6289300 0.73 PARP10 (0.51) SLC6A4CXCL8SLC6A2SLC6A3ALDH1A1
SCHEMBL6293774 0.73 PARP10 (0.51) SLC6A4CXCL8SLC6A2SLC6A3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6933411-B2 Aromatic diamine and polyimide thereof MITSUI CHEMICALS, INC. (JP) 2005-08-23 US disclosed
US-6737503-B2 LOW TEMPERATURE ADHESIVE BONDING MITSUI CHEMICALS, INC. (JP) 2004-05-18 US disclosed
US-20040082754-A1 Novel aromatic diamine and polyimide thereof MITSUI CHEMICALS, INC. (JP) 2004-04-29 US disclosed
US-20030092870-A1 Novel aromatic diamine and polyimide thereof MITSUI CHEMICALS, INC. (JP) 2003-05-15 US disclosed
EP-1288191-A2 Novel aromatic diamine and polyimide thereof Mitsui Chemicals, Inc. (JP) 2003-03-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030092870-A1 Novel aromatic diamine and polyimide thereof DDT, AOC1, H1-4 SLC6A4 1103/4885HTR2A 3542/4885AR 2413/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.